Literature DB >> 9752719

RNA and protein interactions modulated by protein arginine methylation.

J D Gary1, S Clarke.   

Abstract

This review summarizes the current status of protein arginine N-methylation reactions. These covalent modifications of proteins are now recognized in a number of eukaryotic proteins and their functional significance is beginning to be understood. Genes that encode those methyltransferases specific for catalyzing the formation of asymmetric dimethylarginine have been identified. The enzyme modifies a number of generally nuclear or nucleolar proteins that interact with nucleic acids, particularly RNA. Postulated roles for these reactions include signal transduction, nuclear transport, or a direct modulation of nucleic acid interactions. A second methyltransferase activity that symmetrically dimethylates an arginine residue in myelin basic protein, a major component of the axon sheath, has also been characterized. However, a gene encoding this activity has not been identified to date and the cellular function for this methylation reaction has not been clearly established. From the analysis of the sequences surrounding known arginine methylation sites, we have determined consensus methyl-accepting sequences that may be useful in identifying novel substrates for these enzymes and may shed further light on their physiological role.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9752719     DOI: 10.1016/s0079-6603(08)60825-9

Source DB:  PubMed          Journal:  Prog Nucleic Acid Res Mol Biol        ISSN: 0079-6603


  178 in total

1.  Crystal structure of the conserved core of protein arginine methyltransferase PRMT3.

Authors:  X Zhang; L Zhou; X Cheng
Journal:  EMBO J       Date:  2000-07-17       Impact factor: 11.598

2.  Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B/B' and the Sm-like protein LSm4, and their interaction with the SMN protein.

Authors:  H Brahms; L Meheus; V de Brabandere; U Fischer; R Lührmann
Journal:  RNA       Date:  2001-11       Impact factor: 4.942

3.  Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation.

Authors:  Kenichi Nishioka; Sergei Chuikov; Kavitha Sarma; Hediye Erdjument-Bromage; C David Allis; Paul Tempst; Danny Reinberg
Journal:  Genes Dev       Date:  2002-02-15       Impact factor: 11.361

4.  PABP1 identified as an arginine methyltransferase substrate using high-density protein arrays.

Authors:  Jaeho Lee; Mark T Bedford
Journal:  EMBO Rep       Date:  2002-02-15       Impact factor: 8.807

5.  Cascade of distinct histone modifications during collagenase gene activation.

Authors:  Joost H A Martens; Matty Verlaan; Eric Kalkhoven; Alt Zantema
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

6.  Structure of the predominant protein arginine methyltransferase PRMT1 and analysis of its binding to substrate peptides.

Authors:  Xing Zhang; Xiaodong Cheng
Journal:  Structure       Date:  2003-05       Impact factor: 5.006

7.  Epigenetic repression of LEDGF during UVB exposure by recruitment of SUV39H1 and HDAC1 to the Sp1-responsive elements within LEDGF promoter CpG island.

Authors:  Biju Bhargavan; Bhavana Chhunchha; Nigar Fatma; Eri Kubo; Anil Kumar; Dhirendra P Singh
Journal:  Epigenetics       Date:  2013-02-05       Impact factor: 4.528

8.  Methyltransferase PRMT1 is a binding partner of HBx and a negative regulator of hepatitis B virus transcription.

Authors:  Shirine Benhenda; Aurélie Ducroux; Lise Rivière; Bijan Sobhian; Michael D Ward; Sarah Dion; Olivier Hantz; Ulrike Protzer; Marie-Louise Michel; Monsef Benkirane; Oliver J Semmes; Marie-Annick Buendia; Christine Neuveut
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

Review 9.  Readers of histone methylarginine marks.

Authors:  Sitaram Gayatri; Mark T Bedford
Journal:  Biochim Biophys Acta       Date:  2014-02-28

10.  Arginine methylation of MRE11 by PRMT1 is required for DNA damage checkpoint control.

Authors:  François-Michel Boisvert; Ugo Déry; Jean-Yves Masson; Stéphane Richard
Journal:  Genes Dev       Date:  2005-03-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.